Helmut R Maëcke

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
CXCR4 is a target of growing interest for the development of new therapeutic drugs and imaging agents as its role in multiple disease states has been demonstrated. AMD3100, a CXCR4 chemokine receptor antagonist that is in current clinical use as a haematopoietic stem cell mobilising drug, has been widely studied for its anti-HIV properties, potential to(More)
  • 1